A detailed history of Pro Share Advisors LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 9,656 shares of HRMY stock, worth $328,979. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,656
Previous 8,459 14.15%
Holding current value
$328,979
Previous $255,000 50.98%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$30.0 - $39.95 $35,910 - $47,820
1,197 Added 14.15%
9,656 $385,000
Q2 2024

Aug 13, 2024

SELL
$28.81 - $33.01 $58,455 - $66,977
-2,029 Reduced 19.35%
8,459 $255,000
Q1 2024

May 08, 2024

BUY
$29.93 - $35.06 $20,472 - $23,981
684 Added 6.98%
10,488 $352,000
Q4 2023

Feb 14, 2024

BUY
$19.2 - $33.78 $16,320 - $28,713
850 Added 9.49%
9,804 $316,000
Q3 2023

Nov 13, 2023

BUY
$31.89 - $39.03 $63 - $78
2 Added 0.02%
8,954 $293,000
Q2 2023

Aug 10, 2023

BUY
$30.5 - $37.4 $28,182 - $34,557
924 Added 11.51%
8,952 $315,000
Q1 2023

May 11, 2023

SELL
$30.8 - $53.92 $34,372 - $60,174
-1,116 Reduced 12.2%
8,028 $262,000
Q4 2022

Feb 02, 2023

BUY
$45.4 - $60.91 $21,383 - $28,688
471 Added 5.43%
9,144 $503,000
Q3 2022

Nov 04, 2022

BUY
$42.06 - $55.45 $19,642 - $25,895
467 Added 5.69%
8,673 $384,000
Q2 2022

Aug 01, 2022

SELL
$33.54 - $52.15 $100,284 - $155,928
-2,990 Reduced 26.71%
8,206 $400,000
Q1 2022

May 10, 2022

SELL
$33.14 - $51.13 $91,864 - $141,732
-2,772 Reduced 19.85%
11,196 $544,000
Q4 2021

Feb 08, 2022

BUY
$34.09 - $43.91 $476,169 - $613,334
13,968 New
13,968 $595,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.